aldo-keto reductase family 1 member D1
| UniProt | Protein Name |
|---|---|
| P51857 |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| bile acid biosynthetic process | ||
| bile acid biosynthetic process | ||
| cholesterol catabolic process | ||
| digestion | ||
| C21-steroid hormone metabolic process |
| GO Term | Evidence Code | PMID |
|---|---|---|
| alditol:NADP+ 1-oxidoreductase activity | ||
| aldo-keto reductase (NADP) activity | ||
| steroid binding | ||
| protein binding | ||
| steroid dehydrogenase activity |
| Gene Ontology |
|---|
| alditol |
| oxidoreductase activity |
| InterPro |
|---|
| Aldo-keto reductase |
| Aldo/keto reductase, conserved site |
| NADP-dependent oxidoreductase domain superfamily |
| NADP-dependent oxidoreductase domain |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0111069 | congenital bile acid synthesis defect 2 |
| HPO ID | HPO Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000107 | Renal cyst |
| HP:0000952 | Jaundice |
| HP:0001396 | Cholestasis |
| HP:0001397 | Hepatic steatosis |
| HP:0001399 | Hepatic failure |
| HP:0001406 | Intrahepatic cholestasis |
| HP:0001508 | Failure to thrive |
| HP:0001744 | Splenomegaly |
| HP:0001978 | Extramedullary hematopoiesis |
| Disease ID | Disease Name |
|---|---|
| ORPHA:79303 |
|
| OMIM:235555 |
|
| Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
|---|---|---|---|
| 100483237 | AILME17877 | ||
| 100520813 | PIGXX12481 | ||
| 100528314 | ICTPU12579 | ||
| 100547967 | MELGA00661 | ||
| 100555605 | ANOCA06812 | ||
| 100596284 | NOMLE07676 | ||
| 100665738 | LOXAF04021 | ||
| 100710661 | ORENI69919 | ||
| 100713034 | CAVPO06907 | ||
| 100770348 | CRIGR11064 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025